200 related articles for article (PubMed ID: 31519123)
21. Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model.
Gassner FJ; Zaborsky N; Catakovic K; Rebhandl S; Huemer M; Egle A; Hartmann TN; Greil R; Geisberger R
Br J Haematol; 2015 Aug; 170(4):515-22. PubMed ID: 25940792
[TBL] [Abstract][Full Text] [Related]
22. Chronic lymphocytic leukemia presence impairs antigen-specific CD8
Martens AWJ; Kavazović I; Krapić M; Pack SM; Arens R; Jongejan A; Moerland PD; Eldering E; van der Windt GJW; Wensveen FM; Peters FS; Kater AP
Leukemia; 2023 Mar; 37(3):606-616. PubMed ID: 36658390
[TBL] [Abstract][Full Text] [Related]
23. T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.
Riches JC; Davies JK; McClanahan F; Fatah R; Iqbal S; Agrawal S; Ramsay AG; Gribben JG
Blood; 2013 Feb; 121(9):1612-21. PubMed ID: 23247726
[TBL] [Abstract][Full Text] [Related]
24. Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic Leukemia.
Parigger T; Gassner FJ; Scherhäufl C; Bakar AA; Höpner JP; Hödlmoser A; Steiner M; Catakovic K; Geisberger R; Greil R; Zaborsky N
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206229
[TBL] [Abstract][Full Text] [Related]
25. Frequency and functional characterization of exhausted CD8
Taghiloo S; Allahmoradi E; Tehrani M; Hossein-Nataj H; Shekarriz R; Janbabaei G; Abediankenari S; Asgarian-Omran H
Eur J Haematol; 2017 Jun; 98(6):622-631. PubMed ID: 28306177
[TBL] [Abstract][Full Text] [Related]
26. Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.
Reinart N; Nguyen PH; Boucas J; Rosen N; Kvasnicka HM; Heukamp L; Rudolph C; Ristovska V; Velmans T; Mueller C; Reiners KS; von Strandmann EP; Krause G; Montesinos-Rongen M; Schlegelberger B; Herling M; Hallek M; Fingerle-Rowson G
Blood; 2013 Jan; 121(5):812-21. PubMed ID: 23118218
[TBL] [Abstract][Full Text] [Related]
27. CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic Leukemia.
Allahmoradi E; Taghiloo S; Tehrani M; Hossein-Nattaj H; Janbabaei G; Shekarriz R; Asgarian-Omran H
Iran J Immunol; 2017 Dec; 14(4):257-269. PubMed ID: 29276179
[TBL] [Abstract][Full Text] [Related]
28. Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eµ-TCL1 transgenic mice.
Collard JP; McKenna MK; Noothi SK; Alhakeem SS; Rivas JR; Rangnekar VM; Muthusamy N; Bondada S
Leuk Lymphoma; 2022 Aug; 63(8):1810-1822. PubMed ID: 35258388
[TBL] [Abstract][Full Text] [Related]
29. BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia.
Smith AL; Skupa SA; Eiken AP; Reznicek TE; Schmitz E; Williams N; Moore DY; D'Angelo CR; Kallam A; Lunning MA; Bociek RG; Vose JM; Mohamed E; Mahr AR; Denton PW; Powell B; Bollag G; Rowley MJ; El-Gamal D
JCI Insight; 2024 May; 9(10):. PubMed ID: 38775157
[TBL] [Abstract][Full Text] [Related]
30. PD-1 AND TIM-3 BLOCKING CANNOT ENHANCE APOPTOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS INDUCED BY PERIPHERAL BLOOD CD8
Jafarkhani S; Hossein-Nataj H; Eslami-Jouybari M; Ghoreishi M; Asgarian-Omran H
Exp Oncol; 2022 Dec; 44(4):287-294. PubMed ID: 36811540
[TBL] [Abstract][Full Text] [Related]
31. BCL-2 expression promotes immunosuppression in chronic lymphocytic leukemia by enhancing regulatory T cell differentiation and cytotoxic T cell exhaustion.
Liu L; Cheng X; Yang H; Lian S; Jiang Y; Liang J; Chen X; Mo S; Shi Y; Zhao S; Li J; Jiang R; Yang DH; Wu Y
Mol Cancer; 2022 Feb; 21(1):59. PubMed ID: 35193595
[TBL] [Abstract][Full Text] [Related]
32. Combined Blockade Of PD-1 and TIGIT is not Sufficient to Improve the Function Of CD8+ T-Cells in Chronic Lymphocytic Leukemia.
Hatefi F; Asgarian-Omran H; Hossein-Nataj H; Akbar A; Shekarriz R; Zaboli E; Janbabai G; Tehrani M
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2225-2231. PubMed ID: 35901326
[TBL] [Abstract][Full Text] [Related]
33. CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia.
te Raa GD; Pascutti MF; García-Vallejo JJ; Reinen E; Remmerswaal EB; ten Berge IJ; van Lier RA; Eldering E; van Oers MH; Tonino SH; Kater AP
Blood; 2014 Jan; 123(5):717-24. PubMed ID: 24246502
[TBL] [Abstract][Full Text] [Related]
34. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.
Tinhofer I; Marschitz I; Kos M; Henn T; Egle A; Villunger A; Greil R
Blood; 1998 Jun; 91(11):4273-81. PubMed ID: 9596676
[TBL] [Abstract][Full Text] [Related]
35. CD73 Promotes Chronic Lymphocytic Leukemia.
Allard D; Chrobak P; Bareche Y; Allard B; Tessier P; Bergeron MA; Johnson NA; Stagg J
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804900
[TBL] [Abstract][Full Text] [Related]
36. CD8+ T-cells Co-expressing PD-1 and TIGIT Are Highly Frequent in Chronic Lymphocytic Leukemia.
Hajiasghar-Sharbaf R; Asgarian-Omran H; Valadan R; Hossein-Nattaj H; Shekarriz R; Zaboli E; Janbabaei G; Tehrani M
Iran J Allergy Asthma Immunol; 2021 Dec; 20(6):751-763. PubMed ID: 34920658
[TBL] [Abstract][Full Text] [Related]
37. Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion.
Ahn E; Youngblood B; Lee J; Lee J; Sarkar S; Ahmed R
J Virol; 2016 Oct; 90(19):8934-46. PubMed ID: 27466420
[TBL] [Abstract][Full Text] [Related]
38. Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors.
Takamura S; Tsuji-Kawahara S; Yagita H; Akiba H; Sakamoto M; Chikaishi T; Kato M; Miyazawa M
J Immunol; 2010 May; 184(9):4696-707. PubMed ID: 20351188
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia.
Pagano G; Botana IF; Wierz M; Roessner PM; Ioannou N; Zhou X; Al-Hity G; Borne C; Gargiulo E; Gonder S; Qu B; Stamatopoulos B; Ramsay AG; Seiffert M; Largeot A; Moussay E; Paggetti J
Haematologica; 2023 Nov; 108(11):3011-3024. PubMed ID: 37345470
[TBL] [Abstract][Full Text] [Related]
40. Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia.
Rezvany MR; Jeddi-Tehrani M; Wigzell H; Osterborg A; Mellstedt H
Blood; 2003 Feb; 101(3):1063-70. PubMed ID: 12393705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
